When would you offer post-operative concurrent chemoradiation in anaplastic thyroid cancer?
Would you consider it for a patient with good PS but with limited metastatic disease? What dose fractionation would you prefer?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on
The management of ATC has evolved considerably over recent years with the most significant being a dichotomy of management based on Braf mutation.
We typically offer postoperative XRT, including in patients with either a limited or stable DM disease. However, in a multidisciplinary setting, there so...
Join for free or sign in to see the full answer